Verena Baake
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Verena Baake has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Raymund A.C. Roos
From the Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands (VB, RACR); the Huntington Center Topaz Overduin, Katwijk, the Netherlands (VB); the Department of Psychiatry, Leiden University Medical Center, Leiden, the Netherlands (EvD); and the Mental Health Care Centre Delfland, Delft, the Netherlands (EvD)
4 shared publicationsErik van Duijn
From the Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands (VB, RACR); the Huntington Center Topaz Overduin, Katwijk, the Netherlands (VB); the Department of Psychiatry, Leiden University Medical Center, Leiden, the Netherlands (EvD); and the Mental Health Care Centre Delfland, Delft, the Netherlands (EvD)
2 shared publicationsEve M. Dumas
Leiden University Medical Center, Department of Neurology, Leiden, The Netherlands; Tongerschans General Hospital, Heerenveen, The Netherlands
2 shared publicationsAlexandra Durr
ICM - Institut du Cerveau et de la Moelle Epinière, INSERM U1127, CNRS UMR7225, Sorbonne Universités - UPMC Université Paris VI UMR_S1127and APHP, Genetic Department, Pitié-Salpêtrière University Hospital, Paris, France
1 shared publicationBlair Leavitt
Centre for Molecular Medicine and Therapeutics, Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada
1 shared publicationDavid Craufurd
Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester M13 9PL, UK; Manchester Centre for Genomic Medicine, St. Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Oxford Road, Manchester M13 9WL, UK
1 shared publication
Latest Publications
- 1 July 2018
- Published by American Psychiatric Association Publishing in The Journal of Neuropsychiatry and Clinical Neurosciences
- Vol. 30 (3) , 183-187
Huntington’s Disease Gene Expansion Carriers Are Aware of Their Degree of Apathy
Huntington’s disease is characterized by motor and behavioral symptoms as well as cognitive decline. Apathy is a common behavioral symptom, and its severity is related to disease progression. It has been suggested that Huntington’s disease gene expansion carriers (HDGECs) are unaware of the signs and symptoms of the disease, which may account for their own level of awareness of their apathy. Therefore, the authors investigated the level of agreement on the degree of apathy severity between HDGECs and their proxies by using a self-report questionnaire. A total of 109 REGISTRY participants (premotormanifest, N=31; early motormanifest, N=49; and late motormanifest, N=29) and their proxies completed the Apathy Evaluation Scale. The authors used the Wilcoxon signed-rank test to assess whether gene expansion carriers and their proxies agreed on apathy severity. Scores on the Apathy Evaluation Scale significantly increased from the early motormanifest stage to the late motormanifest stage. Premotormanifest carriers scored themselves significantly higher on the Apathy Evaluation Scale than their proxies, whereas no differences were found between all motormanifest carriers and their proxies. Apathy severity increases in the motormanifest stages of Huntington’s disease. HDGECs can adequately assess their level of apathy on a self-report questionnaire. These results also suggest that slight changes in the degree of apathy among premotormanifest gene expansion carriers remain unnoticed by their proxies.
- 1 July 2018
- Published by American Psychiatric Association Publishing in The Journal of Neuropsychiatry and Clinical Neurosciences
- Vol. 30 (3) , 183-187
Huntington’s Disease Gene Expansion Carriers Are Aware of Their Degree of Apathy
Huntington’s disease is characterized by motor and behavioral symptoms as well as cognitive decline. Apathy is a common behavioral symptom, and its severity is related to disease progression. It has been suggested that Huntington’s disease gene expansion carriers (HDGECs) are unaware of the signs and symptoms of the disease, which may account for their own level of awareness of their apathy. Therefore, the authors investigated the level of agreement on the degree of apathy severity between HDGECs and their proxies by using a self-report questionnaire. A total of 109 REGISTRY participants (premotormanifest, N=31; early motormanifest, N=49; and late motormanifest, N=29) and their proxies completed the Apathy Evaluation Scale. The authors used the Wilcoxon signed-rank test to assess whether gene expansion carriers and their proxies agreed on apathy severity. Scores on the Apathy Evaluation Scale significantly increased from the early motormanifest stage to the late motormanifest stage. Premotormanifest carriers scored themselves significantly higher on the Apathy Evaluation Scale than their proxies, whereas no differences were found between all motormanifest carriers and their proxies. Apathy severity increases in the motormanifest stages of Huntington’s disease. HDGECs can adequately assess their level of apathy on a self-report questionnaire. These results also suggest that slight changes in the degree of apathy among premotormanifest gene expansion carriers remain unnoticed by their proxies.
- Open Access
- 1 January 2018
- Published by Elsevier in NeuroImage: Clinical
- Vol. 19, 66-70
Apathy and atrophy of subcortical brain structures in Huntington's disease: A two-year follow-up study
- 1 January 2018
- Published by Elsevier in NeuroImage: Clinical
- Vol. 19, 66-70
Open AccessApathy and atrophy of subcortical brain structures in Huntington's disease: A two-year follow-up study
- 31 March 2016
- Published by SAGE Publications in Journal of Huntington's Disease
- Vol. 5 (1) , 83-90
Participants at the Leiden Site of the REGISTRY Study: A Demographic Approach
Background: REGISTRY is the largest European observational study of Huntington’s disease (HD). The Leiden University Medical Center (LUMC) in The Netherlands is the largest recruiting site. REGISTRY is the largest European observational study of Hunt
- 31 March 2016
- Published by SAGE Publications in Journal of Huntington's Disease
- Vol. 5 (1) , 83-90
Participants at the Leiden Site of the REGISTRY Study: A Demographic Approach
Background: REGISTRY is the largest European observational study of Huntington’s disease (HD). The Leiden University Medical Center (LUMC) in The Netherlands is the largest recruiting site. REGISTRY is the largest European observational study of Hunt